Previous close | 4.3500 |
Open | 3.7000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 160.00 |
Expiry date | 2024-07-19 |
Day's range | 3.5500 - 4.7600 |
Contract range | N/A |
Volume | |
Open interest | 1.38k |
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.